SecBot SecBot

Priority for Pediatric Cures Act

H.R. 10359 Rep. Gus Bilirakis (R-FL-12) In committee
Bill text PDF
  1. Introduced Sep 14
  2. Committee Sep 14
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 14, 2026Next: House vote
43d ago Sep 14, 2026: Referred to the House Committee on Energy and Commerce.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
4companies, 5 filings
Subscribe to see spend
Member trades
1trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

4 companies
Companies by sector
Biotech & Pharma 4
Search all 4 companies, their asks and price moves Subscribe

Summary

This bill permanently extends the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products. Sec. 2, Permanent extension of authority to award priority review vouchers for rare pediatric disease products: The bill amends the Federal Food, Drug, and Cosmetic Act by removing paragraph (5) of section 529(b), which had previously limited the authority to award these vouchers, thereby making the program permanent.

Summary of the bill text as introduced in House (Sep 14, 2026), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.